Publicacións en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (27)

2024

  1. Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer

    The Journal of clinical investigation, Vol. 134, Núm. 10

2023

  1. METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

    Molecular cancer, Vol. 22, Núm. 1, pp. 119

  2. Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution

    Frontiers in Immunology, Vol. 14

2022

  1. MEK inhibitor sensitivity in BRAF fusion-driven prostate cancer

    Clinical and Translational Oncology, Vol. 24, Núm. 12, pp. 2432-2440

2019

  1. CREBBP/EP300 bromodomain inhibition affects the proliferation of AR-positive breast cancer cell lines

    Molecular Cancer Research, Vol. 17, Núm. 3, pp. 720-730

2018

  1. CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation

    Epigenetics and Chromatin, Vol. 11, Núm. 1

2017

  1. Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Núm. 25, pp. E4951-E4960

2016

  1. NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation

    Scientific Reports, Vol. 6

2013

  1. An Epistatic Interaction between the PAX8 and STK17B Genes in Papillary Thyroid Cancer Susceptibility

    PLoS ONE, Vol. 8, Núm. 9

2012

  1. Genome-wide analysis of Pax8 binding provides new insights into thyroid functions

    BMC Genomics, Vol. 13, Núm. 1

2009

  1. The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors

    PLoS Genetics, Vol. 5, Núm. 9

2007

  1. Association study of 69 genes in the ret pathway identifies low-penetrance loci in sporadic medullary thyroid carcinoma

    Cancer Research, Vol. 67, Núm. 19, pp. 9561-9567

  2. Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients

    Human Mutation, Vol. 28, Núm. 6, pp. 613-621

2006

  1. Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: A possible hot spot?

    Genes Chromosomes and Cancer, Vol. 45, Núm. 3, pp. 213-219

2005

  1. A novel candidate region linked to development of both pheochromocytoma and head/neck paraganglioma

    Genes Chromosomes and Cancer, Vol. 42, Núm. 3, pp. 260-268

  2. Brief report: Succinate dehydrogenase D variants do not constitute a risk factor for developing C cell hyperplasia or sporadic medullary thyroid carcinoma

    Journal of Clinical Endocrinology and Metabolism, Vol. 90, Núm. 4, pp. 2127-2130

2004

  1. Genetic Characterization and Structural Analysis of VHL Spanish Families to Define Genotype-Phenotype Correlations

    Human Mutation, Vol. 23, Núm. 2, pp. 160-169

  2. Genetic and epigenetic profile of sporadic pheochromocytomas.

    Journal of medical genetics, Vol. 41, Núm. 3

  3. PupaSNP Finder: A web tool for finding SNPs with putative effect at transcriptional level

    Nucleic Acids Research, Vol. 32, Núm. WEB SERVER ISS.

  4. The RET IVS1-126G>T Variant Is Strongly Associated with the Development of Sporadic Medullary Thyroid Cancer [2]

    Thyroid